Autonomic nervous system and diabetes;Il sistema nervoso autonomo nel diabete

Italian Heart Journal Supplement

Volumn 2, Issue 8, 2001, Pages 857-864

  Emdin, M ^a  

^a CNR   (Italy)

Author keywords

Autonomic nervous system; Diabetes; Heart rate variability; Hyperinsulinemia; Insulin

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); AMINOGUANIDINE; ANGIOTENSIN; AUTOANTIBODY; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CATECHOLAMINE; CORTICOTROPIN RELEASING FACTOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GAMMA LINOLENIC ACID; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; INSULIN; MIDODRINE; N(G) METHYLARGININE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; THIOCTIC ACID; VASODILATOR AGENT; ZOPOLRESTAT;

AUTONOMIC NERVOUS SYSTEM; CLINICAL TRIAL; DIABETES MELLITUS; DIABETIC NEUROPATHY; HEART RATE VARIABILITY; HEART REPOLARIZATION; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN RESISTANCE; ORTHOSTATIC HYPERTENSION; PRESSORECEPTOR; PROGNOSIS; REVIEW;

AUTONOMIC NERVOUS SYSTEM; CARDIOVASCULAR SYSTEM; DIABETES COMPLICATIONS; DIABETES MELLITUS; DIABETIC NEUROPATHIES; HUMANS; HYPERINSULINISM; INSULIN;

EID: 0034758002     PISSN: 11294728     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (59)

1. Autonomic and hemodynamic responses to insulin in lean and obese humans
2. Insulin: New roles for an ancient hormone
3. Insulin prolongs the QTc interval in humans
4. General characteristics of the insulin resistance syndrome. Prevalence and heritability
5. Hyperinsulinemia and autonomic nervous system dysfunction in obesity: Effects of weight loss
6. Glucose clamp technique: A method for quantifying insulin secretion and resistance
7. Effect of insulin on membrane potential and potassium content of rat muscle
8. Insulin as a vascular and sympathoexcitatory hormone. Implications for blood pressure regulation, insulin sensitivity, and cardiovascular morbidity
9. Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release
10. Nitric oxide release accounts for insulin's vascular effects in humans
11. Effects of insulin-glucose infusion on left ventricular function at rest and during dynamic exercise in healthy subjects and noninsulin-dependent diabetic patients: A radionuclide ventriculographic study
12. Insulin in the brain: A hormonal regulator of energy balance
13. Evidence that the brain of the conscious dog is insulin sensitive
14. The sympathetic response to euglycaemic hyperinsulinaemia. Evidence from microelectrode nerve recordings in healthy subjects
15. Linear and nonlinear properties of heart rate variability: Influence of obesity
16. + pump
17. Sympathetic activation in obese normotensive subjects
18. Hyperinsulinemia predicts coronary heart disease risk in healthy middle-aged men: The 22-year follow-up results of the Helsinki Policemen Study
19. Persistent elevation of plasma insulin levels is associated with increased cardiovascular risk in children and young adults. The Bogalusa Heart Study
20. Pathogenesis of type 2 diabetes mellitus: A balanced overview
21. La neuropatia diabetica
22. Diabetic neuropathy
23. The effect of intensive treatment of diabetes on the development and progression of neuropathy
24. The pathology of human diabetic neuropathy
25. Ultrastructural changes of human cardiac atrial nerve endings in diabetes mellitus
26. The natural history of diabetic autonomic neuropathy
27. Clinical evaluation of arterial baroreflex activity in diabetes
28. Cardiac and plasma catecholamine responses to exercise in patients with type 2 diabetes: Prognostic implications for cardiac-cerebrovascular events
29. Plasma epinephrine and norepinephrine response to stimuli in autonomic neuropathy of type 2 diabetes mellitus
30. Impaired modulation of circadian rhythms in patients with diabetes mellitus: A risk factor for cardiac thrombotic events?
31. Association of hyperglycemia with reduced heart rate variability (the Framingham Heart Study)
32. Association of vagal tone with serum insulin, glucose, and diabetes mellitus. The ARIC Study
33. Cardiac autonomic dysfunction in diabetic children
34. Reduction of 0.1 Hz microcirculatory fluctuations as evidence of sympathetic dysfunction in insulin-dependent diabetes
35. Scintigraphic assessment of regionalized defects in myocardial sympathetic innervation and blood flow regulation in diabetic patients with autonomic neuropathy
36. Metaiodobenzylguanidine imaging in diabetes mellitus: Assessment of cardiac sympathetic denervation and its relation to autonomic dysfunction and silent myocardial ischemia
37. Diagnosis of cardiovascular autonomic neuropathy in diabetes
38. Impaired circadian modulation of sympathovagal activity in diabetes. A possible explanation for altered temporal onset of cardiovascular disease
39. The value of cardiovascular autonomic function tests: Ten year experience in diabetes
40. Evidence of defective cardiovascular regulation in insulin-dependent diabetic patients without clinical autonomic dysfunction
41. Noninvasive exploration of cardiac autonomic neuropathy. Four reliable methods for diabetes?
42. Assessing cardiovascular autonomic neuropathy in diabetes mellitus: How many tests to use?
43. The natural history of recently diagnosed autonomic neuropathy over a period of 2 years
44. Autonomic neuropathy: A complication less pronounced in patients with type 1 diabetes mellitus who have lower blood glucose levels
45. QT interval prolongation predicts cardiovascular mortality in an apparent healthy population
46. QTc duration is associated with levels of insulin and glucose intolerance. The Zutphen Elderly Study
47. QT interval prolongation and sudden cardiac death in diabetic autonomic neuropathy
48. QT and QTc dispersion are accurate predictors of cardiac death in newly diagnosed non-insulin-dependent diabetes: Cohort study
49. Prolongation of QTc interval and autonomic nervous dysfunction in diabetic patients
50. 123I-MIBG myocardial scintigraphy and power spectral analysis of heart rate variability
51. 123I-metaiodobenzylguanidine uptake in newly diagnosed IDDM patients
52. Noninvasive assessment of cardiac diabetic neuropathy by carbon-11 hydroxyephedrine and positron-emission tomography
53. Effect of intensive blood glucose control with metformin on complications in overweight patients with type 2 diabetes
54. Regression and progression of cardiac sympathetic dysinnervation complicating diabetes: An assessment by C-11 hydroxyephedrine and positron emission tomography
55. Effect of glycemic control on heart rate variability in type I diabetic patients with cardiac autonomic neuropathy
56. Effects of physical training on heart rate variability in diabetic patients with various degrees of cardiovascular autonomic neuropathy
57. Can diabetic neuropathy be prevented by angiotensin-converting enzyme inhibitors?
58. New treatments for diabetic neuropathy
59. Beta-blocker prescribing differences in patients with and without diabetes following a first myocardial infarction